Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MEK1 Antikörper

Der Maus Monoklonal Anti-MEK1-Antikörper wurde für WB und FACS validiert. Er ist geeignet, MEK1 in Proben von Human, Maus und Ratte zu detektieren.
Produktnummer ABIN4915400

Kurzübersicht für MEK1 Antikörper (ABIN4915400)

Target

Alle MEK1 (MAP2K1) Antikörper anzeigen
MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))

Reaktivität

  • 346
  • 187
  • 180
  • 35
  • 29
  • 19
  • 13
  • 12
  • 12
  • 8
  • 7
  • 5
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 313
  • 31
  • 3
  • 2
  • 2
Maus

Klonalität

  • 272
  • 79
Monoklonal

Konjugat

  • 182
  • 19
  • 14
  • 12
  • 11
  • 10
  • 8
  • 8
  • 8
  • 8
  • 8
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
Dieser MEK1 Antikörper ist unkonjugiert

Applikation

  • 221
  • 114
  • 89
  • 68
  • 66
  • 47
  • 34
  • 26
  • 23
  • 18
  • 15
  • 9
  • 8
  • 7
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)

Klon

8C8
  • Kreuzreaktivität

    Human, Maus, Ratte

    Aufreinigung

    Purified by Protein G.

    Immunogen

    This MP2K1 antibody is generated from a mouse immunized with a recombinant protein between 1-393 amino acids from human MP2K1.

    Isotyp

    IgG1
  • Applikationshinweise

    WB 1:300-5000
    FCM 1:20-100

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.5 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C for 12 months.

    Haltbarkeit

    12 months
  • Target

    MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))

    Andere Bezeichnung

    MP2K1

    Hintergrund

    Synonyms: CFC3, MEK1, MKK1, MAPKK1, PRKMK1, Dual specificity mitogen-activated protein kinase kinase 1, MAP kinase kinase 1, MAPKK 1, ERK activator kinase 1, MAPK/ERK kinase 1, MEK 1, MAP2K1

    Background: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

    Gen-ID

    5604

    UniProt

    Q02750

    Pathways

    MAPK Signalweg, RTK Signalweg, Interferon-gamma Pathway, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagie, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling
Sie sind hier:
Chat with us!